Early detection of cancer.
Assay Type | Targeted hybrid capture NGS based on proprietary HQS™ technology |
Sample Requirement | 20mL of whole blood or CSF, 40mL of PE or Ascites (cfDNA input amount: 5-30ng) |
Panel Size | 466kb |
No. of genes | 118 genes (including 15 HRR genes) |
Detected Alterations (5) | SNVs, Indels, CNAs, Fusions, HRR |
Detected Signatures | MSI, TMB |
*HRR (Homologous recombination repair) genes: genes involved in repair of damaged DNA
Reportable Range | Allelic Fraction / Copy Number | Analytical Sensitivity | Analytical Specificity | |
---|---|---|---|---|
SNV | ≥ 0.03% | ≥ 0.1% | 95% | 100% |
≥ 0.5% | 99% | |||
Indel | ≥ 0.01% | ≥ 0.1% | 95% | 100% |
≥ 0.5% | 99% | |||
CNA | ≥ 2.2 copies | ≥ 2.4 copies | 99% | 100% |
CNA | ≥ 0.05% | ≥ 0.2% | 95% | 100% |
Minimum of 10mL of patient's whole blood is collected, stored and shipped in a tube that stabilizes cfDNA (eg., Streck tube), which are then sent to IMBdx's central laboratory for analysis
cfDNA is isolated from blood and undergoes Quality Control (QC). QC-passed samples are then prepared into NGS libraries through an automated proprietary process, after which high-throughput NGS is performed.
Various genetic alternations (SNVs, Indels, CNAs, Fusions, HRR) and signatures (MSI, TMB, LOH) are analyzed from the NGS data using IMBdx's patented, machine-learning enabled bioinformatics pipeline.
A clinical analysis report is generated and sent to the treating physician, providing information including detected variants and matching guideline-recommended therapy options, longitudinal tumor response analytics, as well as relevant on-going clinical trials.
Upon receiving patient samples, IMBdx carries out all necessary workflows for the AlphaLiquid® 100 assay including NGS library preparation, sequencing run, and BI analysis. A final clinical report is provided within 7-10 days from sample arrival
Sample Shipment to IMBdx
Clinical Report Delivery
Clinical Report Delivery
AlphaLiquid® 100 is also available as a remote testing service, where NGS assay workflows (library prep and sequencing) can be conducted locally. NGS data is transferred via a secure cloud platform to IMBdx which conducts the BI analysis and clinical report generation. IMBdx provides the AlphaLiquid® 100 panel, reagents, as well as technical support for the local laboratory where NGS workflows are conducted.
BMG LAB SERVICES is ready to take care of you.
Copyright © 2022 by Bangkok Molecular Genetics. All Rights Reserved.